[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:gastrointestinal-stromal-tumor:kit-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Gastrointestinal Stromal Tumor","KIT Gene",10,[8,16,22,29,36,43,49,55,61,67],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07218926","A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy",[12],"Phase 3","RECRUITING","2026-08-26T02:17:21.315591Z","2026-07-05T05:32:16.663184Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05208047","(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors",[12],"2026-08-26T02:18:45.196599Z","2026-06-17T02:29:30.056293Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07171203","Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor",[26],"Phase 1","2026-08-26T02:17:00.709807Z","2026-06-16T05:54:07.933748Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06630234","A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)",[33],"Phase 1\u002FPhase 2","2026-08-26T02:16:42.787115Z","2026-05-05T02:43:29.051332Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":41,"content_modified":42},"NCT05366816","ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST",[40],"Phase 2","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:27.815567Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":47,"content_modified":48},"NCT07406633","KQB198 in Combination With Imatinib in Participants With Advanced\u002FMetastatic GIST in 1st Line Setting",[40],"2026-08-26T02:15:48.613507Z","2026-05-05T02:43:27.814895Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT06655246","A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)",[26],"2026-08-26T02:18:43.501109Z","2026-05-05T02:43:27.645419Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT05493215","Imatinib TDM in GIST",[40],"2026-08-26T02:18:19.586423Z","2026-05-05T02:43:27.434422Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT05957367","A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies",[33],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:26.929806Z",{"nct_id":68,"title":69,"phases":70,"status":71,"updated_at":72,"content_modified":73},"NCT05489237","First-in-human Study of IDRX-42 in Participants With Metastatic and\u002For Unresectable Gastrointestinal Stromal Tumors",[26],"ACTIVE_NOT_RECRUITING","2026-08-03T03:33:02.530589Z","2026-05-05T02:43:29.679210Z"]